Sunrest Lifescience Limited IPO

Sunrest Lifescience Limited is listed in the SME segment with a price band of ₹84 to ₹84. The figures below are as reported by the exchanges and public sources.

Sunrest Lifescience Limited IPO — key facts

• The Sunrest Lifescience Limited IPO price band is ₹84 to ₹84 per share.
• As of 5 September 2026, the Sunrest Lifescience Limited IPO subscription status is 48.54x overall.
• The issue is open from 07-NOV-2023 to 09-NOV-2023.
• Sunrest Lifescience Limited listed on 20-NOV-2023.
• Sunrest Lifescience Limited listed at ₹79.8. The listing loss was 5.0% against the upper end of the issue price band.

Sunrest Lifescience Limited IPO details

Status

Listed

Segment

SME

Sector

Pharmaceuticals

Price band

₹84 – ₹84

Issue size

₹10.3 Cr

Fresh issue

₹10.3 Cr

Opens

07-NOV-2023

Closes

09-NOV-2023

Listing

20-NOV-2023

Total subscription

48.54x

Retail

65.74x

NII

29.17x

Lead managers

Mark Corporate (left lead)

Listing price

₹79.8

Listing day change

-5.0%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.